UK’s NICE wants more effectiveness data on Lilly’s tirzepatide
The United Kingdom’s National Institute for Health and Care Excellence (NICE) is asking Eli Lilly for more data about tirzepatide before it will recommend the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.